2024
F35. INVESTIGATING GENETIC RISK FOR PSYCHOSIS IN BIPOLAR DISORDER IN INDIA USING POLYGENIC SCORES
Jeevan Y, Mahadevan J, Viswanath B, Jain S, Ganesh S, Holla B, Purushottam M, Shankarappa B, consortium A, India S. F35. INVESTIGATING GENETIC RISK FOR PSYCHOSIS IN BIPOLAR DISORDER IN INDIA USING POLYGENIC SCORES. European Neuropsychopharmacology 2024, 87: 224. DOI: 10.1016/j.euroneuro.2024.08.446.Peer-Reviewed Original ResearchPsychotic symptomsBipolar disorderPolygenic scoresGenetic susceptibility to bipolar disorderAbsence of psychotic symptomsHistory of psychotic symptomsPresence of psychotic symptomsClinical heterogeneity of BDCourse of maniaSchizophrenia polygenic scoreRisk of psychosisChronic mental disordersHeterogeneity of BDSusceptibility to bipolar disorderOdds of psychosisRisk of BDEpisodic courseBD-PRSMental disordersPsychosisIndependent dimensionsBD-1Investigate genetic riskGenetic riskManiaBehavioral, Cognitive and Electrophysiological Presentation and Short-Term Course of Cannabis Related First Episode Psychosis
D'Souza D, Raj J, Ganesh S, Goyal N, Vidya K, Tikka S, Shreekantiah U, Murthy P, Sinha V, Ram D, Cortes J. Behavioral, Cognitive and Electrophysiological Presentation and Short-Term Course of Cannabis Related First Episode Psychosis. Biological Psychiatry 2024, 95: s29. DOI: 10.1016/j.biopsych.2024.02.076.Peer-Reviewed Original Research
2023
The Acute Effects of Cannabinoids in Patients with Psychotic Illness
Ganesh S, Henquet C, Sewell R, Kuepper R, Ranganathan M, D’Souza D. The Acute Effects of Cannabinoids in Patients with Psychotic Illness. 2023, 225-239. DOI: 10.1017/9781108943246.023.Peer-Reviewed Original ResearchMental illnessMental health teamsHealth policy implicationsHigh-potency cannabisStages of neurodevelopmentPotential adverse effectsAcute effectsHealth teamsPsychotic illnessImpact of exposureCannabis dependenceAdverse effectsIllnessCannabisCannabinoidsSynthetic cannabinoidsPsychosisNew research findingsAssociationComplex associationPatientsNeurodevelopmentPutative modelSchizophrenia
2019
O11.2. CHARACTERIZING CANNABINOID INDUCED ACUTE PERSISTENT PSYCHOSIS (CIAPP) AS A POSSIBLE SUBTYPE OF SCHIZOPHRENIA USING DEEP LEARNING
Ganesh S, Vidya K, Tikka S, Raj J, Gahalout R, Skosnik P, Luddy C, Goyal N, Ram D, D’Souza D, Cortes-Briones J. O11.2. CHARACTERIZING CANNABINOID INDUCED ACUTE PERSISTENT PSYCHOSIS (CIAPP) AS A POSSIBLE SUBTYPE OF SCHIZOPHRENIA USING DEEP LEARNING. Schizophrenia Bulletin 2019, 45: s194-s194. PMCID: PMC6455269, DOI: 10.1093/schbul/sbz021.258.Peer-Reviewed Original Research20.1 BEHAVIORAL, COGNITIVE, AND PSYCHOPHYSIOLOGICAL CHARACTERIZATION AND SHORT-TERM COURSE OF CANNABINOID- INDUCED ACUTE PERSISTENT PSYCHOSIS (CIAPP)
D’Souza D, KL V, Tikka S, Raj J, Gahalout R, Skosnik P, Luddy C, Goyal N, Khess C, Sinha V, Ram D, Ganesh S, Cortes-Briones J. 20.1 BEHAVIORAL, COGNITIVE, AND PSYCHOPHYSIOLOGICAL CHARACTERIZATION AND SHORT-TERM COURSE OF CANNABINOID- INDUCED ACUTE PERSISTENT PSYCHOSIS (CIAPP). Schizophrenia Bulletin 2019, 45: s121-s122. PMCID: PMC6455882, DOI: 10.1093/schbul/sbz022.080.Peer-Reviewed Original Research